Publications
Innovation policy instruments (non-price) for medical innovation
Report report for World Health Organization Europe Office / Oslo Medicines Initiative (contributing author)
September 2022
This Oslo Medicines Initiative technical report presents a broad range of instruments available to national policy-makers in support of innovation for new medicines (excluding those focused on price) explores various types of policy instrument, based on reviews of the literature on policies for innovation in the medical and other sectors.
Valuing Vaccines: Ensuring Australia's access to vaccines today and tomorrow
Report commissioned by Sanofi
February 2022
Report prepared on trends in global health, health policy, health technology assessment and Australia's place in the global context
Submission to the PBAC on the Base Case Discount Rate
Report commissioned by Medicines Australia and prepared with Biointelect.
January 2022
Medicines Australia's submission to Australia's Pharmaceutical Benefits Advisory Committee on the rationale for reducing the base case discount rate used by the PBAC to evaluate medicines and vaccines for public subsidy.
Getting Australia to the front of the queue
Report prepared for Johnson & Johnson
December 2021
Report prepared on trends in global health, health policy, health technology assessment and Australia's place in the global context